NEW YORK (GenomeWeb) – Mergers and acquisitions in the omics life science tools and molecular diagnostics industries slowed in the first half of 2017, down 14 percent from H1 2016.

According to an analysis by GenomeWeb, the first six months of the year saw the announcement of 30 deals, down from 35 completed deals in H1 2016. This brings the number of deals so far this year back down to H1 2015 levels.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.